Serum Biomarkers of Clinical and Radiographic Disease Progression in Multiple Sclerosis

被引：0

作者：

Qureshi, Ferhan ^{[1
]}

Oechtering, Johanna ^{[2
,3
,4
,5
,6
]}

Keshavan, Anisha ^{[1
]}

McCurdy, Shannon ^{[1
]}

Maceski, Aleksandra Maleska ^{[2
,3
,4
,5
,6
]}

Willemse, Eline ^{[2
,3
,4
,5
,6
]}

Meier, Stephanie ^{[2
,3
,4
,5
,6
]}

Ghoreyshi, Ati ^{[1
]}

Jalaleddini, Kian ^{[1
]}

Leyden, Kelly ^{[1
]}

Leppert, David ^{[2
,3
,4
,5
,6
]}

Melie-Garcia, Lester ^{[2
,3
,4
,5
,6
,7
]}

Granziera, Cristina ^{[2
,3
,4
,5
,6
,7
]}

Schadelin, Sabine ^{[2
,3
,4
,5
,6
]}

Benkert, Pascal ^{[2
,3
,4
,5
,6
]}

Kuhle, Jens ^{[2
,3
,4
,5
,6
]}

机构：

[1] Octave Biosci, Menlo Pk, CA USA

[2] Univ Hosp, Basel, Switzerland

[3] Univ Basel, Dept Neurol, Basel, Switzerland

[4] Multiple Sclerosis Ctr, Basel, Switzerland

[5] Res Ctr Clin Neuroimmunol & Neurosci RC2NB, Dept Biomed, Basel, Switzerland

[6] Res Ctr Clin Neuroimmunol & Neurosci RC2NB, Dept Clin Res, Basel, Switzerland

[7] Translat Imaging Neurol ThINk, Dept Biomed Engn, Basel, Switzerland

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P235/1117

引用

页码：302 / 303

页数：2

共 50 条

[1] Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis
Chitnis, Tanuja
Qureshi, Ferhan
Gehman, Victor M.
Becich, Michael
Bove, Riley
Cree, Bruce A. C.
Gomez, Refujia
Hauser, Stephen L.
Henry, Roland G.
Katrib, Amal
Lokhande, Hrishikesh
Paul, Anu
Caillier, Stacy J.
Santaniello, Adam
Sattarnezhad, Neda
Saxena, Shrishti
Weiner, Howard
Yano, Hajime
Baranzini, Sergio E.
[J]. NATURE COMMUNICATIONS, 2024, 15 (01)
[2] Serum Lactate and Uric Acid as Biomarkers for Disease Activity and Progression in Multiple Sclerosis
Hassan, Amr
Mehaney, Dina
[J]. EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2015, 52 (02): : 127 - 131
[3] Relevance of biomarkers in disease progression in multiple sclerosis
Kanodia, A. K.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (01) : 7 - 8
[4] Multiple serum biomarkers associate with mortality and interstitial lung disease progression in systemic sclerosis
Parker, Matthew James Sinclair
Jee, Adelle S.
Hansen, Dylan
Proudman, Susanna
Youssef, Peter
Kenna, Tony J.
Stevens, Wendy
Nikpour, Mandana
Sahhar, Joanne
Corte, Tamera J.
[J]. RHEUMATOLOGY, 2024,
[5] Serum proteomics in multiple sclerosis disease progression
Tremlett, Helen
Dai, Darlene L. Y.
Hollander, Zsuzsanna
Kapanen, Anita
Aziz, Tariq
Wilson-McManus, Janet E.
Tebbutt, Scott J.
Borchers, Christoph H.
Oger, Joel
Freue, Gabriela V. Cohen
[J]. JOURNAL OF PROTEOMICS, 2015, 118 : 2 - 11
[6] CSF Biomarkers of Disease Progression in Patients with Multiple Sclerosis
Zanker, Shayna
Harris, Violaine
Sadiq, Saud
[J]. NEUROLOGY, 2017, 88
[7] Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis
Giovannoni, G
Miller, DH
Losseff, NA
Sailer, M
Lewellyn-Smith, N
Thompson, AJ
Thompson, EJ
[J]. JOURNAL OF NEUROLOGY, 2001, 248 (06) : 487 - 495
[8] Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis
G. Giovannoni
D.H. Miller
N.A. Losseff
M. Sailer
N. Lewellyn-Smith
A.J. Thompson
E.J. Thompson
[J]. Journal of Neurology, 2001, 248 : 487 - 495
[9] A Highly Sensitive Proteomic Immunoassay to Identify Novel Serum Biomarkers for Multiple Sclerosis Disease Progression
Van Lierop, Z.
In't Veld, S.
Noteboom, S.
Willemse, E.
Schoonheim, M.
Steenwijk, M.
Geurts, J.
Uitdehaag, B.
Killestein, J.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 155 - 155
[10] Extending lipid biomarkers of disease progression in people with multiple sclerosis
Mckechnie, Charlie
Gafson, Arie
Savva, Constantinos
Matthews, Paul
[J]. NEUROLOGY, 2017, 88

← 1 2 3 4 5 →